Individual patient data meta-analyses of randomized trials for the treatment of non-metastatic head and neck squamous cell carcinomas: Principles, results and perspectives

被引:2
|
作者
Blanchard, P. [1 ,2 ,3 ]
Bourhis, J. [4 ]
Lacas, B. [1 ,3 ,5 ]
Le Teuff, G. [1 ,3 ,5 ]
Michiels, S. [1 ,3 ,5 ]
Pignon, J. -P. [1 ,3 ,5 ]
机构
[1] Gustave Roussy, Serv Biostat & Epidemiol, F-94800 Villejuif, France
[2] Gustave Roussy, Dept Radiotherapie, F-94800 Villejuif, France
[3] Univ Paris 11, CESP, INSERM, U1018, Villejuif, France
[4] CHU Vaudois, CH-1011 Lausanne, Switzerland
[5] Gustave Roussy, Plateforme Ligue Natl Canc Metaanal Oncol, F-94800 Villejuif, France
来源
CANCER RADIOTHERAPIE | 2015年 / 19卷 / 03期
关键词
Head and neck cancer; Chemotherapy; Radiotherapy; Meta-analysis; Randomized trials; Individual patient data; Network meta-analysis; Surrogate marker; LOCALLY ADVANCED HEAD; NASOPHARYNGEAL CARCINOMA; SYSTEMATIC REVIEWS; RADIATION-THERAPY; PUBLICATION BIAS; CHEMOTHERAPY; RADIOTHERAPY; CANCER; AMIFOSTINE; SURVIVAL;
D O I
10.1016/j.canrad.2014.12.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Meta-analyses are considered as an important pillar of evidence-based medicine. The aim of this review is to describe the main principles of a meta-analysis and to use examples of head and neck oncology to demonstrate their clinical impact and methodological interest. The major role of individual patient data is outlined, as well as the superiority of individual patient data over meta-analyses based on published summary data. The major clinical breakthrough of head and neck meta-analyses are summarized, regarding concomitant chemotherapy, altered fractionated chemotherapy, new regimens of induction chemotherapy or the use of radioprotectants. Recent methodological developments are described, including network meta-analyses, the validation of surrogate markers. Lastly, the future of meta-analyses is discussed in the context of personalized medicine. (C) 2015 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:198 / 204
页数:7
相关论文
共 16 条
  • [11] Anti-PD1/PD-L1 monotherapy vs standard of care in patients with recurrent or metastatic head and neck squamous cell carcinoma A meta-analysis of randomized controlled trials
    Zhu, Peng
    Wang, Yanwei
    Zhang, Wendi
    Liu, Xin
    MEDICINE, 2021, 100 (04)
  • [12] a non Platinum regimen for the Treatment of recurrent or Metastatic Squamous Cell Carcinoma of the Head and neck region. results From an Extended Phase II Study With Paclitaxel and Capecitabine
    Bentzen, Jens K. D.
    Kristensen, Claus Andrup
    Overgaard, Marie
    Rytter, Carsten
    Jensen, Kenneth
    Hansen, Hanne Sand
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [13] Why have meta-analyses of randomized controlled trials of the association between non-white-blood-cell-reduced allogeneic blood transfusion and postoperative infection produced discordant results?
    Vamvakas, E. C.
    VOX SANGUINIS, 2007, 93 (03) : 196 - 207
  • [14] PRE-OPERATIVE CHEMOTHERAPY IMPROVES SURVIVAL AND REDUCES RECURRENCE IN OPERABLE NON-SMALL CELL LUNG CANCER: PRELIMINARY RESULTS OF A SYSTEMATIC REVIEW AND META-ANALYSIS OF INDIVIDUAL PATIENT DATA FROM 13 RANDOMISED TRIALS
    Burdett, Sarah
    Rydzewska, Larysa H.
    Tierney, Jayne F.
    Pignon, Jean-Pierre
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S374 - S375
  • [15] Therapeutic effects and associated adverse events of PD-1 and CTLA-4 pathway inhibitors in the treatment of non-small-cell lung cancer: meta-analyses of clinical phase II/III randomized controlled trials
    Zhan, Hui
    Yang, Yang
    Zhao, Bing
    Hao, Shuguang
    Hou, Xiabao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 1529 - 1538
  • [16] BENEFITS AND RISKS OF USING ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN NON-SMALL CELL LUNG CANCER (NSCLC) AND SMALL CELL LUNG CANCER (SCLC) PATIENTS: RESULTS FROM STUDY-LEVEL AND PATIENT-LEVEL META-ANALYSES OF CONTROLLED ESA TRIALS IN LUNG CANCER
    Vansteenkiste, Johan
    Glaspy, John
    Henry, David
    Ludwig, Heinz
    Pirker, Robert
    Tomita, Dianne
    Collins, Helen
    Crawford, Jeffrey
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S645 - S646